🇺🇸 Subcutaneous immune globulin G in United States

Subcutaneous immune globulin G (Subcutaneous immune globulin G) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Subcutaneous immune globulin G in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Subcutaneous immune globulin G approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Subcutaneous immune globulin G in United States?

Rutgers, The State University of New Jersey is the originator. The local marketing authorisation holder may differ — check the official source linked above.